Insulin Pumps and Accessories Global Market – Forecast To 2026

Publishing Date : December, 2019
Report Code : HCMD0163
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Insulin pumps and accessories are class of medical devices used for administering insulin in a controlled, precise and automated manner. These devices used in the treatment of diabetes mellitus know as continuous subcutaneous insulin infusion, these insulin systems help in avoiding medical errors which would lead to serious life-threatening circumstances or even sometimes to death of a patient.

Insulin pumps & accessories market is segmented on the basis of products, applications, end-users and geography. The insulin pumps & accessories products market is segmented into insulin pumps, consumables, among them insulin pumps held the largest share of the market with XX% in 2019 and are expected to grow at a high single digit CAGR of XX% from 2019 to 2026. Insulin pumps are further sub-segmented into tethered insulin pumps and patch insulin pumps. The tethered insulin pump accounted for the largest share of XX% in 2019 and is expected to grow at a mid single digit CAGR of XX% from 2019 to 2026. Applications market is segmented into type 1 diabetes and type 2 diabetes, among them, the type 1 diabetes segment held the largest share of XX% in 2019 and is expected to be the fastest growing segment with a high single digit CAGR of XX% from 2019 to 2026. End-users market is classified into hospitals, ambulatory surgical centers, homecare and others. Among them, home healthcare commanded the largest share of XX% in 2019 and is expected to be the fastest growing segment with a high single digit CAGR of XX% from 2019 to 2026.

Geographically, North America is the largest market, with a share of XX% followed by Europe and Asia Pacific. The APAC region is the fastest growing region and is expected to grow at a high single digit CAGR of XX% from 2019 to 2026 presenting an array of opportunities for growth and is likely to get the attention of new investors in the insulin pumps & accessories market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases and government initiatives in establishing innovative technologies and demand for sophisticated medical services.

The insulin pumps & accessories market is expected to grow at a high single digit CAGR of XX% from 2019 to 2026. Increase in the prevalence of diabetes, technological advancements, adoption of insulin pumps over traditional methods and advantages of insulin pumps over the injections and pens are the factors driving the market growth. The increasing trend for wireless insulin pumps, emergence of smart pumps and market expansion in emerging nations and product approvals are expected to offer potential opportunities.

However, various factors like, high cost, patient safety risks and medication errors associated with insulin pumps, lack of cyber-security in wireless insulin pumps limit the growth of insulin pumps & accessories global market.

The insulin pumps & accessories global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Major players in insulin pumps & accessories market include F. Hoffmann-La Roche AG (Switzerland),  Insulet Corporation (U.S.), Medtronic PLC  (Ireland), Tandem Diabetes Care Inc. (U.S.), Valeritas Holdings Inc. (U.S.) and Ypsomed Holdings AG (Switzerland).

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

  • North America
  • U.S.
  • Rest of North America
  • Europe
  • Germany
  • France
  • U.K.
  • Rest of Europe
  • Asia-Pacific 
  • Japan
  • China
  • India
  • Rest of APAC
  • Rest of the World (RoW)
  • Brazil
  • Rest of Latin America
  • Middle East and Others
  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     SCOPE OF THE REPORT
    • 2.3     REPORT DESCRIPTION
    • 2.4     MARKETS COVERED
    • 2.5     STAKEHOLDERS
    • 2.6     RESEARCH METHODOLOGY
      • 2.6.1     MARKET SIZE ESTIMATION
      • 2.6.2     MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.6.3     SECONDARY SOURCES
      • 2.6.4     PRIMARY SOURCES
      • 2.6.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.6.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.6.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     THE GLOBAL RISE IN THE PREVALENCE AND INCIDENCE OF DIABETES
        • 3.3.1.2     INCREASE IN THE USE OF INSULIN PUMPS IN-HOME CARE SETTINGS AND DISADVANTAGES OF CONVENTIONAL METHODS OVER INSULIN PUMPS.
        • 3.3.1.3     INCREASING DISTRIBUTION AGREEMENTS, PARTNERSHIPS AND COLLABORATION ACTIVITIES
        • 3.3.1.4     INCREASE IN PRODUCT APPROVALS
      • 3.3.2     RESTRAINS AND THREATS
        • 3.3.2.1     HIGH COST OF THE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION THERAPY(CSII)
        • 3.3.2.2     INADEQUATE REIMBURSEMENT
        • 3.3.2.3     INCREASED PRODUCT RECALLS
        • 3.3.2.4     PRIVACY CONCERN AND SAFETY ISSUES ASSOCIATED WITH INSULIN PUMPS
        • 3.3.2.5     STRINGENT REGULATORY REQUIREMENTS FOR NEW PRODUCTS
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1     INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
        • 3.4.1.1     ISO:9001: 2015 QUALITY MANAGEMENT SYSTEM
        • 3.4.1.2     ISO:13485 MEDICAL DEVICES
      • 3.4.2     U.S.
      • 3.4.3     CANADA
      • 3.4.4     EUROPE
      • 3.4.5     INDIA
      • 3.4.6     CHINA
      • 3.4.7     JAPAN
    • 3.5     CLINICAL TRIALS
    • 3.6     PRODUCT RECALLS
    • 3.7     PORTER’S FIVE FORCE ANALYSIS
      • 3.7.1     THREAT OF NEW ENTRANTS
      • 3.7.2     THREAT OF SUBSTITUTES
      • 3.7.3     RIVALRY AMONG EXISTING COMPETITORS
      • 3.7.4     BARGAINING POWER OF SUPPLIERS
      • 3.7.5     BARGAINING POWER OF BUYERS
    • 3.8     SUPPLY CHAIN ANALYSIS
    • 3.9     MARKET SHARE ANALYSIS BY MAJOR PLAYERS
      • 3.9.1     INSULIN PUMPS AND ACCESSORIES MARKET SHARE ANALYSIS
    • 3.10     NUMBER OF UNITS SOLD
    • 3.11     MARKET PENETRATION
  • 4     INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET, BY PRODUCTS
    • 4.1     INTRODUCTION
    • 4.2     INSULIN PUMPS
      • 4.2.1     TETHERED INSULIN PUMP
      • 4.2.2     PATCH INSULIN PUMP
    • 4.3     CONSUMABLES
  • 5     INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET, BY APPLICATION
    • 5.1     INTRODUCTION
    • 5.2     TYPE 1 DIABETES
    • 5.3     TYPE 2 DIABETES
  • 6     INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET, BY END-USER
    • 6.1     INTRODUCTION
    • 6.2     HOSPITALS
    • 6.3     AMBULATORY SURGICAL CENTERS
    • 6.4     HOME HEALTHCARE
    • 6.5     OTHERS
  • 7     INSULIN PUMPS AND ACCESSORIES MARKET BY REGION
    • 7.1     INTRODUCTION
    • 7.2     NORTH AMERICA
      • 7.2.1     U.S.
      • 7.2.2     REST OF NORTH AMERICA
    • 7.3     EUROPE
      • 7.3.1     GERMANY
      • 7.3.2     FRANCE
      • 7.3.3     U.K.
      • 7.3.4     REST OF EUROPE
    • 7.4     APAC
      • 7.4.1     JAPAN
      • 7.4.2     CHINA
      • 7.4.3     INDIA
      • 7.4.4     REST OF APAC
    • 7.5     REST OF THE WORLD
      • 7.5.1     BRAZIL
      • 7.5.2     REST OF LATIN AMERICA
      • 7.5.3     MIDDLE EAST AND OTHERS
  • 8     COMPETITIVE LANDSCAPE
    • 8.1     INTRODUCTION
    • 8.2     APPROVAL
    • 8.3     AGREEMENTS, PARTERNERSHIPS AND COLLABORATIONS
    • 8.4     NEW PRODUCT LAUNCH
    • 8.5     OTHERS
  • 9     MAJOR COMPANIES
    • 9.1     DEBIOTECH S.A.
      • 9.1.1     OVERVIEW
      • 9.1.2     FINANCIALS
      • 9.1.3     PRODUCT PORTFOLIO
      • 9.1.4     KEY DEVELOPMENTS
      • 9.1.5     BUSINESS STRATEGY
      • 9.1.6     SWOT ANALYSIS
    • 9.2     DIABELOOP S.A.
      • 9.2.1     OVERVIEW
      • 9.2.2     FINANCIALS
      • 9.2.3     PRODUCT PORTFOLIO
      • 9.2.4     KEY DEVELOPMENTS
      • 9.2.5     BUSINESS STRATEGY
      • 9.2.6     SWOT ANALYSIS
    • 9.3     F. HOFFMANN-LA ROCHE AG.
      • 9.3.1     OVERVIEW
      • 9.3.2     FINANCIALS
      • 9.3.3     PRODUCT PORTFOLIO
      • 9.3.4     KEY DEVELOPMENTS
      • 9.3.5     BUSINESS STRATEGY
      • 9.3.6     SWOT ANALYSIS
    • 9.4     INSULET CORPORATION
      • 9.4.1     OVERVIEW
      • 9.4.2     FINANCIALS
      • 9.4.3     PRODUCT PORTFOLIO
      • 9.4.4     KEY DEVELOPMENTS
      • 9.4.5     BUSINESS STRATEGY
      • 9.4.6     SWOT ANALYSIS
    • 9.5     MEDTRONIC PLC
      • 9.5.1     OVERVIEW
      • 9.5.2     FINANCIALS
      • 9.5.3     PRODUCT PORTFOLIO
      • 9.5.4     KEY DEVELOPMENTS
      • 9.5.5     BUSINESS STRATEGY
      • 9.5.6     SWOT ANALYSIS
    • 9.6     MICROPORT SCIENTIFIC CORPORATION
      • 9.6.1     OVERVIEW
      • 9.6.2     FINANCIALS
      • 9.6.3     PRODUCT PORTFOLIO
      • 9.6.4     KEY DEVELOPMENTS
      • 9.6.5     BUSINESS STRATEGY
      • 9.6.6     SWOT ANALYSIS
    • 9.7     SOOIL DEVELOPMENT CO. LTD.
      • 9.7.1     OVERVIEW
      • 9.7.2     FINANCIALS
      • 9.7.3     PRODUCT PORTFOLIO
      • 9.7.4     KEY DEVELOPMENTS
      • 9.7.5     BUSINESS STRATEGY
      • 9.7.6     SWOT ANALYSIS
    • 9.8     TANDEM DIABETES CARE INC.
      • 9.8.1     OVERVIEW
      • 9.8.2     FINANCIALS
      • 9.8.3     PRODUCT PORTFOLIO
      • 9.8.4     KEY DEVELOPMENTS
      • 9.8.5     BUSINESS STRATEGY
      • 9.8.6     SWOT ANALYSIS
    • 9.9     VALERITAS HOLDINGS INC.
      • 9.9.1     OVERVIEW
      • 9.9.2     FINANCIALS
      • 9.9.3     PRODUCT PORTFOLIO
      • 9.9.4     KEY DEVELOPMENTS
      • 9.9.5     BUSINESS STRATEGY
      • 9.9.6     SWOT ANALYSIS
    • 9.10     YPSOMED HOLDING AG.
      • 9.10.1     OVERVIEW
      • 9.10.2     FINANCIALS
      • 9.10.3     PRODUCT PORTFOLIO
      • 9.10.4     KEY DEVELOPMENTS
      • 9.10.5     BUSINESS STRATEGY
      • 9.10.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 2     INSULIN PUMPS GLOBAL UNITS SOLD, BY REGION, (2018-2026) (NOS.)
      • TABLE 3     INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET REVENUE, BY PRODUCTS (2018-2026) ($MN)
      • TABLE 4     INSULIN PUMPS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 5     INSULIN PUMPS GLOBAL MARKET REVENUE, BY PRODUCT (2018-2026) ($MN)
      • TABLE 6     TETHERED INSULIN PUMP GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 7     PATCH INSULIN PUMPS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 8     CONSUMABLES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 9     INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET REVENUE, BY APPLICATION (2018-2026) ($MN)
      • TABLE 10     TYPE 1 DIABETES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 11     TYPE 2 DIABETES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN) (2018-2026) ($MN)
      • TABLE 12     INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET REVENUE, BY END-USER (2018-2026) ($MN)
      • TABLE 13     HOSPITAL GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 14     AMBULATORY GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 15     HOME HEALTHCARE GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 16     OTHER END-USER GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • TABLE 17     INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
      • TABLE 18     NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCTS (2018-2026) ($MN)
      • TABLE 19     NORTH AMERICA INSULIN PUMPS MARKET REVENUE, BY PRODUCTS (2018-2026) ($MN)
      • TABLE 20     NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2018-2026) ($MN)
      • TABLE 21     NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2018-2026) ($MN)
      • TABLE 22     NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY COUNTRY (2018-2026) ($MN)
      • TABLE 23     EUROPE INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCTS (2018-2026) ($MN)
      • TABLE 24     EUROPE INSULIN PUMPS MARKET REVENUE, BY PRODUCTS (2018-2026) ($MN)
      • TABLE 25     EUROPE INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2018-2026) ($MN)
      • TABLE 26     EUROPE INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2018-2026) ($MN)
      • TABLE 27     EUROPE INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY COUNTRY (2018-2026) ($MN)
      • TABLE 28     APAC INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCTS (2018-2026) ($MN)
      • TABLE 29     APAC INSULIN PUMPS MARKET REVENUE, BY PRODUCTS (2018-2026) ($MN)
      • TABLE 30     APAC INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2018-2026) ($MN)
      • TABLE 31     APAC INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2018-2026) ($MN)
      • TABLE 32     APAC INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY COUNTRY (2018-2026) ($MN)
      • TABLE 33     ROW INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCTS (2018-2026) ($MN)
      • TABLE 34     ROW INSULIN PUMPS MARKET REVENUE, BY PRODUCTS (2018-2026) ($MN)
      • TABLE 35     ROW INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2018-2026) ($MN)
      • TABLE 36     ROW INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2018-2026) ($MN)
      • TABLE 37     ROW INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY COUNTRY (2018-2026) ($MN)
      • TABLE 38     APPROVALS (2018-2019)
      • TABLE 39     AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES (2018-2019)
      • TABLE 40     NEW PRODUCT LAUNCH (2018-2019)
      • TABLE 41     OTHERS (2018-2019)
      • TABLE 42     F. HOFFMANN-LA ROCHE AG: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) (Q3) ($MN)
      • TABLE 43     F. HOFFMANN-LA ROCHE AG: TOTAL REVENUE BY SEGMENTS, (2017-2019) (Q3) ($MN)
      • TABLE 44     F. HOFFMANN-LA ROCHE AG: DIAGNOSTICS REVENUE, BY TYPES, (2017-2019) (Q3) ($MN)
      • TABLE 45     F. HOFFMANN-LA ROCHE AG: DIABETES CARE REVENUE, BY GEOGRAPHY, (2017-2019) (Q3) ($MN)
      • TABLE 46     F. HOFFMANN-LA ROCHE AG: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) (Q3) ($MN)
      • TABLE 47     INSULET CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) (Q3) ($MN)
      • TABLE 48     INSULET CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2017-2019) (Q3) ($MN)
      • TABLE 49     INSULET CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2017-2019) (Q3) ($MN)
      • TABLE 50     MEDTRONIC PLC: TOTAL REVENUE AND R&D EXPENSES (2016-2018) ($MN)
      • TABLE 51     MEDTRONIC PLC: TOTAL REVENUE, BY SEGMENTS (2016-2018) ($MN)
      • TABLE 52     MEDTRONIC PLC: TOTAL REVENUE, BY REGIONS (2016-2018) ($MN)
      • TABLE 53     MICROPORT SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2017-2019) (Q2) ($MN)
      • TABLE 54     MICROPORT SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENTS (2017-2019) (Q2)($MN)
      • TABLE 55     MICROPORT SCIENTIFIC CORPORATION: TOTAL REVENUE, BY REGIONS (2017-2019) (Q2) ($MN)
      • TABLE 56     TANDEM DIABETES CARE, INC.: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) (Q3) ($MN)
      • TABLE 57     TANDEM DIABETES CARE, INC.: TOTAL REVENUE, BY SEGMENTS, (2017-2019) (Q3) ($MN)
      • TABLE 58     TANDEM DIABETES CARE, INC.: TOTAL REVENUE, BY GEOGRAPHY (2017-2019) (Q3) ($MN)
      • TABLE 59     VALERITAS HOLDINS INC.: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) (Q2) ($MN)
      • TABLE 60     YPSOMED HOLDING AG: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) (Q2) ($MN)
      • TABLE 61     YPSOMED HOLDING AG: TOTAL REVENUE, BY SEGMENTS, (2017-2019) (Q2) ($MN)
      • TABLE 62     YPSOMED HOLDING AG: TOTAL REVENUE, BY GEOGRAPHY (2017-2019) (Q2) ($MN)

      LIST OF FIGURES

      • FIGURE 1     INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET
      • FIGURE 3     INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET: MARKET BREAKDOWN AND DATA TRIANGULATION
      • FIGURE 6     INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 9     INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
      • FIGURE 10     INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2019 (%)
      • FIGURE 11     INSULIN PUMPS UNITS SOLD, BY REGION AND COUNTRYWISE, (2019) (NOS.)
      • FIGURE 12     INSULIN PUMPS MARKET PENETRATION, (2019)
      • FIGURE 13     INSULIN PUMPS MARKET PENETRATION IN TYPE 1 AND TYPE 2 DIABETES, (2019)
      • FIGURE 14     INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
      • FIGURE 15     INSULIN PUMP GLOBAL MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
      • FIGURE 16     PATCH INSULIN PUMP GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
      • FIGURE 17     CONSUMABLES GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
      • FIGURE 18     INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
      • FIGURE 19     INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET SHARE, BY END-USER (2019 V/S 2026) (%)
      • FIGURE 20     HOME HEALTHCARE GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
      • FIGURE 21     INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
      • FIGURE 22     INSULIN PUMPS AND ACCESSORIES GLOBAL MARKET SHARE, BY REGIONAL MARKET REVENUE (2019) (%) ($MN)
      • FIGURE 23     NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
      • FIGURE 24     NORTH AMERICA INSULIN PUMPS MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
      • FIGURE 25     NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
      • FIGURE 26     NORTH AMERICA INSULIN PUMPS MARKET PENETRATION, (2019)
      • FIGURE 27     NORTH AMERICA INSULIN PUMPS MARKET PENETRATION IN TYPE 1 AND TYPE 2 DIABETES, (2019)
      • FIGURE 28     NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY END-USER (2019 V/S 2026) (%)
      • FIGURE 29     NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
      • FIGURE 30     U.S. INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
      • FIGURE 31     U.S. INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
      • FIGURE 32     U.S. INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 33     REST OF NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
      • FIGURE 34     REST NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
      • FIGURE 35     REST OF NORTH AMERICA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 36     EUROPE INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
      • FIGURE 37     EUROPE INSULIN PUMPS MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
      • FIGURE 38     EUROPE INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
      • FIGURE 39     EUROPE INSULIN PUMPS MARKET PENETRATION, (2019)
      • FIGURE 40     EUROPE INSULIN PUMPS MARKET PENETRATION IN TYPE 1 AND TYPE 2 DIABETES, (2019)
      • FIGURE 41     EUROPE INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY END-USER (2019 V/S 2026) (%)
      • FIGURE 42     EUROPE INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
      • FIGURE 43     GERMANY INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
      • FIGURE 44     GERMANY INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
      • FIGURE 45     GERMANY INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 46     FRANCE INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
      • FIGURE 47     FRANCE INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
      • FIGURE 48     FRANCE INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 49     U.K. INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
      • FIGURE 50     U.K. INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
      • FIGURE 51     U.K INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 52     REST OF EUROPE INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
      • FIGURE 53     REST OF EUROPE INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
      • FIGURE 54     REST OF EUROPE INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 55     APAC INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
      • FIGURE 56     APAC INSULIN PUMPS MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
      • FIGURE 57     APAC INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
      • FIGURE 58     APAC INSULIN PUMPS MARKET PENETRATION, (2019)
      • FIGURE 59     APAC INSULIN PUMPS MARKET PENETRATION IN TYPE 1 AND TYPE 2 DIABETES, (2019)
      • FIGURE 60     APAC INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY END-USER (2019 V/S 2026) (%)
      • FIGURE 61     APAC INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
      • FIGURE 62     JAPAN INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
      • FIGURE 63     JAPAN INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
      • FIGURE 64     JAPAN INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 65     CHINA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
      • FIGURE 66     CHINA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
      • FIGURE 67     CHINA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 68     INDIA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
      • FIGURE 69     INDIA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
      • FIGURE 70     INDIA INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 71     REST OF APAC INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
      • FIGURE 72     REST OF APAC INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
      • FIGURE 73     REST OF APAC INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 74     ROW INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
      • FIGURE 75     ROW INSULIN PUMPS MARKET SHARE, BY PRODUCTS (2019 V/S 2026) (%)
      • FIGURE 76     ROW INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY APPLICATION (2019 V/S 2026) (%)
      • FIGURE 77     ROW INSULIN PUMPS MARKET PENETRATION, (2019)
      • FIGURE 78     ROW INSULIN PUMPS MARKET PENETRATION IN TYPE 1 AND TYPE 2 DIABETES, (2019)
      • FIGURE 79     ROW INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY END-USER (2019 V/S 2026) (%)
      • FIGURE 80     ROW INSULIN PUMPS AND ACCESSORIES MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
      • FIGURE 81     BRAZIL INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
      • FIGURE 82     BRAZIL INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
      • FIGURE 83     BRAZIL INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 84     REST OF LATAM INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
      • FIGURE 85     REST OF LATAM INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
      • FIGURE 86     REST OF LATAM INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 87     MIDDLE EAST AND OTHERS INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY PRODUCT (2019 V/S 2026) ($MN)
      • FIGURE 88     MIDDLE EAST AND OTHERS INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY APPLICATION (2019 V/S 2026) ($MN)
      • FIGURE 89     MIDDLE EAST AND OTHERS INSULIN PUMPS AND ACCESSORIES MARKET REVENUE, BY END-USER (2019 V/S 2026) ($MN)
      • FIGURE 90     KEY GROWTH STRATEGIES (2018-2019)
      • FIGURE 91     SWOT: DEBIOTECH S.A.
      • FIGURE 92     SWOT: DIABELOOP S.A.
      • FIGURE 93     SWOT: F. HOFFMANN-LA ROCHE AG
      • FIGURE 94     SWOT: INSULET CORPORATION
      • FIGURE 95     SWOT: MEDTRONIC PLC
      • FIGURE 96     SWOT: MICROPORT SCIENTIFIC CORPORATION.
      • FIGURE 97     SWOT: SOOIL DEVELOPMENT CO. LTD.
      • FIGURE 98     SWOT: TANDEM DIABETES CARE INC.
      • FIGURE 99     SWOT: VALERITAS HOLDINGS, INC.
      • FIGURE 100     SWOT: YPSOMED HOLDING AG

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     DEBIOTECH S.A.
      • 2     DIABELOOP S.A.
      • 3     EOFLOW
      • 4     INSULET CORPORATION
      • 5     JIANGSU DELFU MEDICAL DEVICE CO.,LTD
      • 6     MEDTRONIC, PLC
      • 7     MEDTRUM
      • 8     MEDZER LTD.
      • 9     MICROPORT SCIENTIFIC CORPORATION
      • 10     NOVO NORDISK A/S
      • 11     F. HOFFMANN-LA ROCHE AG
      • 12     ROYAL FORNIA MEDICAL EQUIPMENT CO., LTD.
      • 13     SOOIL DEVELOPMENTS CO., LTD.,
      • 14     TANDEM DIABETES CARE, INC
      • 15     VALERITAS HOLDINGS, INC.
      • 16     VICENTRA B.V.
      • 17     YPSOMED HOLDINGS AG
      • 18     ZHENGZHOU PHRAY TECHNOLOGY CO., LTD